139 related articles for article (PubMed ID: 38341018)
1. A novel three-dimensional Nrf2 reporter epidermis model for skin sensitization assessment.
Brandmair K; Dising D; Finkelmeier D; Schepky A; Kuehnl J; Ebmeyer J; Burger-Kentischer A
Toxicology; 2024 Mar; 503():153743. PubMed ID: 38341018
[TBL] [Abstract][Full Text] [Related]
2. Reconstructed human epidermis-based testing strategy of skin sensitization potential and potency classification using epidermal sensitization assay and in silico data.
Mizumachi H; Suzuki S; Sakuma M; Natsui M; Imai N; Miyazawa M
J Appl Toxicol; 2024 Mar; 44(3):415-427. PubMed ID: 37846211
[TBL] [Abstract][Full Text] [Related]
3. Performance of the N/TERT epidermal model for skin sensitizer identification via Nrf2-Keap1-ARE pathway activation.
Alloul-Ramdhani M; Tensen CP; El Ghalbzouri A
Toxicol In Vitro; 2014 Aug; 28(5):982-9. PubMed ID: 24794257
[TBL] [Abstract][Full Text] [Related]
4. Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis.
Saito K; Nukada Y; Takenouchi O; Miyazawa M; Sakaguchi H; Nishiyama N
Toxicol In Vitro; 2013 Dec; 27(8):2213-24. PubMed ID: 23999411
[TBL] [Abstract][Full Text] [Related]
5. The inter-laboratory validation study of EpiSensA for predicting skin sensitization potential.
Mizumachi H; Watanabe M; Ikezumi M; Kajiwara M; Yasuda M; Mizuno M; Imai N; Sakuma M; Shibata M; Watanabe SI; Motoyama J; Basketter D; Eskes C; Hoffmann S; Lehmann DM; Ashikaga T; Sozu T; Takeyoshi M; Suzuki S; Miyazawa M; Kojima H
J Appl Toxicol; 2024 Apr; 44(4):510-525. PubMed ID: 37897225
[TBL] [Abstract][Full Text] [Related]
6. Gene expression changes induced by skin sensitizers in the KeratinoSens™ cell line: Discriminating Nrf2-dependent and Nrf2-independent events.
Emter R; van der Veen JW; Adamson G; Ezendam J; van Loveren H; Natsch A
Toxicol In Vitro; 2013 Dec; 27(8):2225-32. PubMed ID: 24055896
[TBL] [Abstract][Full Text] [Related]
7. Characterization of dermal sensitization potential for industrial or agricultural chemicals with EpiSensA.
Mizumachi H; LeBaron MJ; Settivari RS; Miyazawa M; Marty MS; Sakaguchi H
J Appl Toxicol; 2021 Jun; 41(6):915-927. PubMed ID: 33124094
[TBL] [Abstract][Full Text] [Related]
8. Transferability and within- and between-laboratory reproducibilities of EpiSensA for predicting skin sensitization potential in vitro: A ring study in three laboratories.
Mizumachi H; Sakuma M; Ikezumi M; Saito K; Takeyoshi M; Imai N; Okutomi H; Umetsu A; Motohashi H; Watanabe M; Miyazawa M
J Appl Toxicol; 2018 Sep; 38(9):1233-1243. PubMed ID: 29722446
[TBL] [Abstract][Full Text] [Related]
9. Applicability of a keratinocyte gene signature to predict skin sensitizing potential.
van der Veen JW; Pronk TE; van Loveren H; Ezendam J
Toxicol In Vitro; 2013 Feb; 27(1):314-22. PubMed ID: 22935770
[TBL] [Abstract][Full Text] [Related]
10. A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells.
McKim JM; Keller DJ; Gorski JR
Cutan Ocul Toxicol; 2010 Sep; 29(3):171-92. PubMed ID: 20491607
[TBL] [Abstract][Full Text] [Related]
11. α-Sens: The improved ARE-Nrf2-based sensitization screening assay using normalized transcriptional activity.
Maeda Y; Takeyoshi M; Chuma T; Iwata H
Toxicology; 2020 Jun; 439():152476. PubMed ID: 32335162
[TBL] [Abstract][Full Text] [Related]
12. An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre/pro-haptens.
Saito K; Takenouchi O; Nukada Y; Miyazawa M; Sakaguchi H
Toxicol In Vitro; 2017 Apr; 40():11-25. PubMed ID: 27965148
[TBL] [Abstract][Full Text] [Related]
13. A triangular approach for the validation of new approach methods for skin sensitization.
Natsch A; Landsiedel R; Kolle SN
ALTEX; 2021; 38(4):669-677. PubMed ID: 34247252
[TBL] [Abstract][Full Text] [Related]
14. Development of an in vitro method to estimate the sensitization induction level of contact allergens.
Galbiati V; Papale A; Marinovich M; Gibbs S; Roggen E; Corsini E
Toxicol Lett; 2017 Apr; 271():1-11. PubMed ID: 28189648
[TBL] [Abstract][Full Text] [Related]
15. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro.
Emter R; Ellis G; Natsch A
Toxicol Appl Pharmacol; 2010 Jun; 245(3):281-90. PubMed ID: 20307559
[TBL] [Abstract][Full Text] [Related]
16. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
McKim JM; Keller DJ; Gorski JR
Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
[TBL] [Abstract][Full Text] [Related]
17. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
Roberts DW; Patlewicz G
J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
[TBL] [Abstract][Full Text] [Related]
18. The THP-1 cell toolbox: a new concept integrating the key events of skin sensitization.
Clouet E; Bechara R; Raffalli C; Damiens MH; Groux H; Pallardy M; Ferret PJ; Kerdine-Römer S
Arch Toxicol; 2019 Apr; 93(4):941-951. PubMed ID: 30806763
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the immune response to contact sensitizers by Nrf2.
Vallion R; Kerdine-Römer S
Contact Dermatitis; 2022 Jul; 87(1):13-19. PubMed ID: 35165896
[TBL] [Abstract][Full Text] [Related]
20. Intra- and inter-laboratory reproducibility and accuracy of the LuSens assay: A reporter gene-cell line to detect keratinocyte activation by skin sensitizers.
Ramirez T; Stein N; Aumann A; Remus T; Edwards A; Norman KG; Ryan C; Bader JE; Fehr M; Burleson F; Foertsch L; Wang X; Gerberick F; Beilstein P; Hoffmann S; Mehling A; van Ravenzwaay B; Landsiedel R
Toxicol In Vitro; 2016 Apr; 32():278-86. PubMed ID: 26796489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
